Using AI to improve iron deficiency treatment in pregnant individuals
An AI-Directed CDS Tool to Reduce Iron Deficiency Anemia in Pregnancy: A Randomized Controlled Trial (AID-IDA Trial)
This study is testing a new tool to help doctors better find and treat iron deficiency in pregnant people, especially those at higher risk for heavy bleeding after giving birth, to improve their health during and after pregnancy.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10951600 on NIH RePORTER |
What this research studies
This research aims to develop an innovative clinical decision support tool that enhances the screening and management of iron deficiency in pregnant individuals, particularly those at high risk for postpartum hemorrhage (PPH). By implementing a novel algorithm, the project seeks to identify and treat iron deficiency more effectively than current practices, which often miss cases due to inadequate screening. The approach involves a randomized controlled trial to evaluate the tool's effectiveness in improving maternal health outcomes during and after pregnancy.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant individuals, especially those identified as being at high risk for postpartum hemorrhage.
Not a fit: Patients who are not pregnant or those who do not have any risk factors for postpartum hemorrhage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of iron deficiency anemia in pregnant individuals, leading to better health outcomes during childbirth.
How similar studies have performed: Other research has shown success with similar clinical decision support tools in improving health outcomes, indicating a promising approach in this area.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Clapp, Mark Allen — Massachusetts General Hospital
- Study coordinator: Clapp, Mark Allen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.